May 28, 2024 09:30AM
May 28, 2024 09:30AM
Dec 20, 2023 08:05AM
Dec 18, 2023 07:33AM
Dec 18, 2023 07:30AM
Jul 31, 2023 09:00AM
May 15, 2023 07:30AM POINT Biopharma Reports First Quarter 2023 Financial Results and Provides Business Highlights
Apr 24, 2023 07:30AM
Apr 24, 2023 07:30AM
Apr 24, 2023 07:30AM
Apr 24, 2023 07:30AM
Dec 20, 2022 08:30AM
Nov 14, 2022 07:15AM
Nov 14, 2022 07:01AM Lantheus Holdings (LNTH) and POINT Biopharma (PNT) Collaborate and Enter License Agreements for the Commercialization of PNT2002 & PNT2003
Nov 14, 2022 07:00AM
Nov 14, 2022 07:00AM
Nov 14, 2022 07:00AM
Aug 8, 2022 08:30AM
Apr 26, 2022 08:30AM
Mar 25, 2022 08:30AM
Sep 14, 2021 07:33AM POINT Biopharma (PNT) Collaborates with Convergent Therapeutics to Evaluate CONV 01-α in Combination With PNT2002 for Progressive Metastatic Castration-Resistant Prostate Cancer
Sep 14, 2021 07:33AM
Sep 8, 2021 08:30AM
Jul 21, 2021 08:09AM
Jul 21, 2021 08:00AM

322,084 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All